 | • レポートコード：MRC-IM30295 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に111.2億ドルであった世界の動物用ワクチン市場規模が、2022年から2027年の間にCAGR 9.60％で成長し、2027年までに196.5億ドルに達すると予測しています。本調査レポートでは、動物用ワクチンの世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、ワクチン種類別（家畜用ワクチン、伴侶動物用ワクチン）分析、技術別（弱毒生ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他）分析、投与経路別（皮下接種、筋肉内接種、経鼻）分析、流通チャネル別（動物病院、動物クリニック、薬局＆ドラッグストア、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA, Zoetis Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の動物用ワクチン市場規模：ワクチン種類別 - 家畜用ワクチンの市場規模 - 伴侶動物用ワクチンの市場規模 ・世界の動物用ワクチン市場規模：技術別 - 弱毒生ワクチンの市場規模 - 不活化ワクチンの市場規模 - トキソイドワクチンの市場規模 - 組換えワクチンの市場規模 - その他ワクチンの市場規模 ・世界の動物用ワクチン市場規模：投与経路別 - 皮下接種ワクチンの市場規模 - 筋肉内接種ワクチンの市場規模 - 経鼻ワクチンの市場規模 ・世界の動物用ワクチン市場規模：流通チャネル別 - 動物病院チャネルの市場規模 - 動物クリニックチャネルの市場規模 - 薬局＆ドラッグストアチャネルの市場規模 - その他流通チャネルの市場規模 ・世界の動物用ワクチン市場規模：地域別 - 北米の動物用ワクチン市場規模 - アジアの動物用ワクチン市場規模 - 欧州の動物用ワクチン市場規模 - 中南米の動物用ワクチン市場規模 - 中東・アフリカの動物用ワクチン市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global veterinary vaccines market size reached US$ 11.12 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 19.65 Billion by 2027, exhibiting a growth rate (CAGR) of 9.60% during 2022-2027.
Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.
Veterinary Vaccines Market Trends:
The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.
Breakup by Vaccine Type:
Livestock Vaccines
Bovine Vaccines
Poultry Vaccines
Porcine Vaccines
Others
Companion Animal Vaccines
Canine Vaccines
Feline Vaccines
Equine Vaccines
Breakup by Technology:
Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
Breakup by Route of Administration:
Subcutaneous
Intramuscular
Intranasal
Breakup by Distribution Channel:
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.
Key Questions Answered in This Report:
How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global veterinary vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global veterinary vaccines market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Veterinary Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Livestock Vaccines
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Bovine Vaccines
6.1.2.2 Poultry Vaccines
6.1.2.3 Porcine Vaccines
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Companion Animal Vaccines
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Canine Vaccines
6.2.2.2 Feline Vaccines
6.2.2.3 Equine Vaccines
6.2.3 Market Forecast
7 Market Breakup by Technology
7.1 Attenuated Live Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Inactivated Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Toxoid Vaccines
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Recombinant Vaccines
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Subcutaneous
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intramuscular
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Intranasal
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Veterinary Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Veterinary Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmacies and Drug Stores
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Boehringer Ingelheim International GmbH
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Ceva Santé Animale
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Elanco Animal Health Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Hester Biosciences Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 HIPRA
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Indian Immunologicals Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck & Co. Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Neogen Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Phibro Animal Health Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Virbac SA
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Zoetis Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2021
Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2021
Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2021
Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2021
Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis
• 日本語訳：動物用ワクチンの世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30295 ▷ お問い合わせ（見積依頼・ご注文・質問）